Skip to main content
Tech.euFundingExplorerBeta

Alithea Genomics

Alithea Genomics backgrounds in bioengineering, molecular biology, genomics and lab operations reflect their complementary expertise.

Alithea Genomics has raised €4.9M across 4 funding rounds from 7 investors, most recently a Seed round in Mar 2026. Based in Lausanne, Switzerland; active in Healthtech. Data as of 28 Oct 2026.

Lausanne, Switzerlandwww.alitheagenomics.com ↗
Healthtech
← All companies
Total raised
€4.9M
€4,926,075
Funding rounds
4
Investors
7
distinct backers
Active since
2021-04
latest 2026-03

Funding by year

EUR raised per year · 2026 YTD
Alithea Genomics — funding by year — interactive chart.
Data table
Alithea Genomics — funding by year
2021€136k
2022€1.0M
2023€502k
2026€3.3M

Signals

High confidence
Raise-next likelihood52
base rate 44% for Seed
  • ▲ In typical raise window
  • ▲ Up-round momentum
  • ▼ Low backer re-investment
Exit likelihood18
base rate 11% (2+ rounds)
  • ▲ 4 rounds raised
  • ▲ 5y since founding (typical exit age)
  • ▲ Recently backed by strong-exit-track investors

Timing: in window vs cohort gap · momentum up. Funding-only estimates, not predictions and not investment advice — see signals.

Funding rounds

4 rounds
DateStageAmountInvestors
2026-03-06Seed€3.3MGenku Ventures,Novalis Biotech,Private Investors,Zürcher KantonalbankView deal →
2023-03-21Debt€502kFoundation for Technological Innovation (FIT)View deal →
2022-05-25Other€1.0MNovalis Biotech Acceleration fund,Private InvestorsView deal →
2021-04-28Other€136kVenture KickView deal →

Investors

7
Foundation for Technological Innovation (FIT)Genku VenturesNovalis BiotechNovalis Biotech Acceleration fundPrivate InvestorsVenture KickZürcher Kantonalbank

Related news

Similar companies

same sector or country

Global coverage: FundingData